XGN

Exagen Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↓ 4/10
  • Value↓ 1/10
Exagen sales and earnings growth
XGN Growth
Neutral
  • Revenue Y/Y↑ 20.55%
  • EPS Y/Y↓ -5.95%
  • FCF Y/Y↑ 8.60%
Exagen gross and profit margin trends
XGN Profitability
Neutral
  • Gross margin ↑ 58.30%
  • EPS margin↓ -29.50%
  • ROIC 5Y↓ -43.19%
Exagen net debt vs free cash flow
XGN Risk
Good
  • Debt / Equity↓ 1.9
  • Debt / FCF↓ 0.4
  • Interest coverage↓ -3.0

Exagen stock volatility is in-line with the overall market. We give it a Good risk rating.

↗ More Diagnostics & Research stocks